国际标准期刊号: 2167-065X

临床药理学与生物药剂学

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • Genamics 期刊搜索
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

The Effectiveness, Safety, Adverse Drug Reactions, and Interchangeability of Biopharmaceuticals as Experienced by Public Hospital Doctors from Various Specialties: a Qualitative Study

Marconi Abreu

Although there's increasing support for biosimilar medicines by the Iraqi Ministry of Health (MOH), there's scarce info concerning whether or not physicians settle for these medicines and support movement toward commutation reference medicines with their biosimilar counterparts. The study objectives were to explore in-depth the perceptions of Iraqi physicians operating publically hospitals concerning the distinction in effectiveness and safety between biosimilar medicines and their reference biological counterparts, assess physicians' barriers to prescribing biosimilar medicines, assess the adherence of physicians to the new pharmacovigilance rules on news biopharmaceutical adverse drug reactions (ADRs) and establish any barriers facing physicians to news biopharmaceutical ADRs.his qualitative study enclosed face-to-face and virtual semi-structured interviews involving physicians from completely different disciplines UN agency had expertise with biological or biosimilar medicines.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。